Annovis Bio Inc (ANVS)
8.73
-0.36
(-3.96%)
USD |
NYSE |
Nov 04, 16:00
8.73
0.00 (0.00%)
Pre-Market: 20:00
Annovis Bio Total Assets (Quarterly): 5.046M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 5.046M |
| March 31, 2024 | 7.813M |
| December 31, 2023 | 10.21M |
| September 30, 2023 | 10.22M |
| June 30, 2023 | 22.82M |
| March 31, 2023 | 25.55M |
| December 31, 2022 | 36.02M |
| September 30, 2022 | 32.49M |
| June 30, 2022 | 36.53M |
| March 31, 2022 | 43.30M |
| December 31, 2021 | 46.00M |
| September 30, 2021 | 47.65M |
| Date | Value |
|---|---|
| June 30, 2021 | 49.50M |
| March 31, 2021 | 5.965M |
| December 31, 2020 | 8.119M |
| September 30, 2020 | 9.402M |
| June 30, 2020 | 10.20M |
| March 31, 2020 | 11.44M |
| December 31, 2019 | 1.117M |
| September 30, 2019 | 0.3799M |
| June 30, 2019 | 0.3005M |
| March 31, 2019 | 0.4313M |
| December 31, 2018 | 0.051M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.117M
Minimum
Dec 2019
49.50M
Maximum
Jun 2021
22.07M
Average
11.44M
Median
Mar 2020
Total Assets (Quarterly) Benchmarks
| Akero Therapeutics Inc | 865.04M |
| Perspective Therapeutics Inc | 385.92M |
| Electromed Inc | 52.23M |
| Xtant Medical Holdings Inc | 95.58M |
| Myomo Inc | 16.19M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.797M |
| Shareholders Equity (Quarterly) | -1.751M |